Create Account | Sign In: Author or Forum

Search Symptoms

Category: Rheumatology | Monthly Briefing

Back to Journal Articles

August 2016 Briefing - Rheumatology

Last Updated: September 01, 2016.

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for August 2016. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis

THURSDAY, Sept. 1, 2016 (HealthDay News) -- A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.

More Information

ACA Is Helping More Americans Afford Prescriptions

WEDNESDAY, Aug. 31, 2016 (HealthDay News) -- Though a growing number of Americans are able to afford prescription medications, millions still have difficulty, according to a study published online Aug. 23 in the American Journal of Public Health.

Full Text (subscription or payment may be required)

Nighttime Sleep Disturbance Common in Chronic Pain

MONDAY, Aug. 29, 2016 (HealthDay News) -- Individuals suffering from chronic pain frequently have nighttime sleep disturbance, and it might be exacerbated by opioid treatment, according to a study published online Aug. 22 in Anaesthesia.

Abstract
Full Text

Plain Radiography Can ID Changes in Gouty Tophi Size

FRIDAY, Aug. 26, 2016 (HealthDay News) -- For patients with tophaceous gout, plain radiography can assess response to hypouricemic treatment, according to a study published online Aug. 12 in the International Journal of Rheumatic Diseases.

Abstract
Full Text (subscription or payment may be required)

Ultrasonography Can Guide Drug Modification in Arthritis

THURSDAY, Aug. 25, 2016 (HealthDay News) -- Ultrasonography can be useful for guiding modification of anti-rheumatic drugs and steroids for patients with inflammatory arthritis (IA), according to a study published online Aug. 19 in the International Journal of Rheumatic Diseases.

Abstract
Full Text (subscription or payment may be required)

Steep Rise in U.S. Drug Prices Tied to Patent Monopolies

WEDNESDAY, Aug. 24, 2016 (HealthDay News) -- Prescription drug prices are skyrocketing in the United States due in large part to government regulations, according to a study published in the Aug. 23/30 issue of the Journal of the American Medical Association.

Abstract
Full Text

Radiofrequency Neurotomy Efficient in Knee Osteoarthritis

TUESDAY, Aug. 23, 2016 (HealthDay News) -- For patients with chronic knee osteoarthritis (OA) pain, radiofrequency (RF) neurotomy of genicular nerves is safe and efficient, according to a study published online Aug. 12 in the International Journal of Rheumatic Diseases.

Abstract
Full Text (subscription or payment may be required)

ACA Has Increased Rx Drug Use, Cut Out-of-Pocket Spending

MONDAY, Aug. 22, 2016 (HealthDay News) -- The Affordable Care Act (ACA) has increased prescription use and reduced out-of-pocket spending, according to a report published online Aug. 17 in Health Affairs.

Abstract
Full Text

Legal Issues Impact Delivery of Telehealth

THURSDAY, Aug. 18, 2016 (HealthDay News) -- Telehealth technologies can allow delivery of high-quality care at a lower cost, especially in underserved areas, but there is currently no uniform legal approach to telehealth, hampering its provision, according to a Health Policy Brief published online Aug. 15 in Health Affairs.

Full Text

Residents Often Order Perceived Unnecessary Lab Tests

WEDNESDAY, Aug. 17, 2016 (HealthDay News) -- Residents frequently order perceived unnecessary inpatient laboratory tests, according to a study published online Aug. 13 in the Journal of Hospital Medicine.

Abstract
Full Text (subscription or payment may be required)

Abaloparatide Reduces Fracture Risk in Women With Osteoporosis

WEDNESDAY, Aug. 17, 2016 (HealthDay News) -- In postmenopausal women with osteoporosis, an experimental drug appears to reduce the risk of bone fractures better than teriparatide or a placebo, according to a study published in the Aug. 16 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

U.S. Female Doctors Reimbursed Significantly Less Than Males

TUESDAY, Aug. 16, 2016 (HealthDay News) -- Female doctors in the United States make much less than their male colleagues, according to a study published online Aug. 15 in the Postgraduate Medical Journal.

Abstract
Full Text

DASH Diet May Be Beneficial for Gout Patients

TUESDAY, Aug. 16, 2016 (HealthDay News) -- The Dietary Approaches to Stop Hypertension (DASH) diet may offer a non-drug treatment for gout, according to a study published online Aug. 15 in Arthritis & Rheumatology.

Abstract
Full Text (subscription or payment may be required)

Arhalofenate Beats Allopurinol for Gout Flares

MONDAY, Aug. 15, 2016 (HealthDay News) -- Arhalofenate (800 mg) is safe and significantly decreases gout flares compared to allopurinol (300 mg), according to a study published online July 27 in Arthritis & Rheumatology.

Abstract
Full Text

Many U.S. Hospitals Offer Language Services

WEDNESDAY, Aug. 10, 2016 (HealthDay News) -- Overall, 68.8 percent of hospitals offer language services, with the proportion increasing with level of need, according to research published in the August issue of Health Affairs.

Abstract
Full Text (subscription or payment may be required)

Water-Based Ai Chi Program Beneficial in Fibromyalgia

WEDNESDAY, Aug. 10, 2016 (HealthDay News) -- A water-based Ai Chi program is associated with improvements in quality of life for women with fibromyalgia syndrome (FMS), according to a study published online July 26 in the International Journal of Rheumatic Diseases.

Abstract
Full Text (subscription or payment may be required)

Soy Isoflavone May Improve Bone Health Post Menopause

THURSDAY, Aug. 4, 2016 (HealthDay News) -- For postmenopausal women, soy isoflavone supplementation is associated with improvement in bone health, according to a study published online July 28 in the Journal of Bone and Mineral Research.

Abstract
Full Text (subscription or payment may be required)

Opioid-Related Insurance Claims Rise 3,000 Percent

WEDNESDAY, Aug. 3, 2016 (HealthDay News) -- The number of private health insurance claims for Americans addicted to opioids and heroin rose 3,203 percent from 2007 to 2014, according to a Fair Health report.

More Information

Overweight/Obesity Up Incidence of Hand, Hip, Knee Osteoarthritis

WEDNESDAY, Aug. 3, 2016 (HealthDay News) -- The incidence of hand, hip, and knee osteoarthritis (OA) increases with overweight and obesity, particularly in the knee, according to a study published in the August issue of Arthritis & Rheumatology.

Abstract
Full Text (subscription or payment may be required)

Biosimilar and Reference TNF-α Inhibitors Comparable

TUESDAY, Aug. 2, 2016 (HealthDay News) -- Biosimilar and reference tumor necrosis factor-α inhibitors appear to be appropriately interchangeable, according to a review published online Aug. 2 in the Annals of Internal Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Urinary Biomarkers Can Predict Response in Lupus Nephritis

TUESDAY, Aug. 2, 2016 (HealthDay News) -- Low abundance biomarker panels can predict lupus nephritis outcomes, according to research published online July 27 in Arthritis & Rheumatology.

Abstract
Full Text (subscription or payment may be required)

European Countries Implementing Cost-Sharing

MONDAY, Aug. 1, 2016 (HealthDay News) -- European health systems are requiring an increase in cost-sharing measures for patients 50 years of age and older, according to research published in the July issue of Health Affairs.

Abstract
Full Text (subscription or payment may be required)


Previous: August 2016 Briefing - Pulmonology Next: August 2016 Briefing - Surgery

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: